European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 10 citations · 65 references
MedicineNeurologyNeuroscienceCognitive NeuroscienceDementiaNeurodegenerationAlzheimer DiseaseAmyloid FormationCognitive ImpairmentDementia BiomarkersDementia Risk FactorsNeurodegenerative DiseasesAlzheimer Disease ProgressionCognitive Decline DetectionLongitudinal Cognitive DeclineMyelin IntegrityMyelin ProteinsPet TracersTau AggregationWhite Matter Microstructure
PURPOSE: The main objectives were to test whether (1) a decrease in myelin is associated with enhanced rate of fibrillar tau accumulation and cognitive decline in Alzheimer's disease, and (2) whether apolipoprotein E (APOE) ε4 genotype is associated with worse myelin decrease and thus tau accumulation. METHODS: To address our objectives, we repurposed florbetapir-PET as a marker of myelin in the white matter (WM) based on previous validation studies showing that beta-amyloid (Aβ) PET tracers bind to WM myelin. We assessed 43 Aβ-biomarker negative (Aβ-) cognitively normal participants and 108 Aβ+ participants within the AD spectrum with florbetapir-PET at baseline and longitudinal flortaucipir-PET as a measure of fibrillar tau (tau-PET) over ~ 2 years. In linear regression analyses, we tested florbetapir-PET in the whole WM and major fiber tracts as predictors of tau-PET accumulation in a priori defined regions of interest (ROIs) and fiber-tract projection areas. In mediation analyses we tested whether tau-PET accumulation mediates the effect of florbetapir-PET in the whole WM on cognition. Finally, we assessed the role of myelin alteration on the association between APOE and tau-PET accumulation. RESULTS: Lower florbetapir-PET in the whole WM or at a given fiber tract was predictive of faster tau-PET accumulation in Braak stages or the connected grey matter areas in Aβ+ participants. Faster tau-PET accumulation in higher cortical brain areas mediated the association between a decrease in florbetapir-PET in the WM and a faster rate of decline in global cognition and episodic memory. APOE ε4 genotype was associated with a worse decrease in the whole WM florbetapir-PET and thus enhanced tau-PET accumulation. CONCLUSION: Myelin alterations are associated in an APOE ε4 dependent manner with faster tau progression and cognitive decline, and may therefore play a role in the etiology of AD.
65
No Adjustments Are Needed for Multiple Comparisons
Kenneth J. Rothman · Epidemiology · 1990 · 5.8K citations
A new rating scale for Alzheimer's disease
Wilma G. Rosen, Richard C. Mohs, Kenneth L. Davis · American Journal of Psychiatry · 1984 · 4.2K citations
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera, Tristan Bolmont, R. Anthony Crowther et al. · Nature Cell Biology · 2009 · 1.8K citations · Full text